LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

Search

Quanterix Corp

Gesloten

SectorGezondheidszorg

5.29 -3.64

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

5.26

Max

5.33

Belangrijke statistieken

By Trading Economics

Inkomsten

-12M

Verkoop

35M

EPS

-0.3

Winstmarge

-33.07

Werknemers

471

EBITDA

3.6M

-11M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+129.73% upside

Dividenden

By Dow Jones

Volgende Winsten

12 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

9.3M

234M

Vorige openingsprijs

8.93

Vorige sluitingsprijs

5.29

Nieuwssentiment

By Acuity

58%

42%

299 / 382 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Neutral Evidence

Quanterix Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 mei 2025, 23:48 UTC

Winsten
Acquisities, Fusies, Overnames

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

11 mei 2025, 23:46 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

11 mei 2025, 23:45 UTC

Marktinformatie

Oil Rises Amid Improved Market Mood -- Market Talk

11 mei 2025, 23:38 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Aristocrat Has Significant Firepower for M&A -- Market Talk

11 mei 2025, 23:36 UTC

Marktinformatie

Global Markets Uncertain About US-China Trade News -- Market Talk

11 mei 2025, 23:35 UTC

Marktinformatie

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

11 mei 2025, 23:33 UTC

Winsten
Acquisities, Fusies, Overnames

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

11 mei 2025, 23:32 UTC

Top Nieuws

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

11 mei 2025, 22:44 UTC

Marktinformatie

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

11 mei 2025, 22:33 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

11 mei 2025, 20:19 UTC

Top Nieuws

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

11 mei 2025, 16:00 UTC

Top Nieuws

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

11 mei 2025, 11:00 UTC

Top Nieuws

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

11 mei 2025, 08:00 UTC

Top Nieuws

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

11 mei 2025, 01:00 UTC

Top Nieuws

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

11 mei 2025, 01:00 UTC

Top Nieuws

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

10 mei 2025, 21:54 UTC

Top Nieuws

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

10 mei 2025, 17:12 UTC

Top Nieuws

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

10 mei 2025, 15:41 UTC

Top Nieuws

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

10 mei 2025, 12:00 UTC

Top Nieuws

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

10 mei 2025, 09:30 UTC

Top Nieuws

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

10 mei 2025, 08:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

10 mei 2025, 03:52 UTC

Top Nieuws

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

9 mei 2025, 23:51 UTC

Acquisities, Fusies, Overnames

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

9 mei 2025, 22:06 UTC

Marktinformatie

Arm Holdings Remains a Strong Growth Story -- Market Talk

9 mei 2025, 21:37 UTC

Top Nieuws

U.S. Sets August Deadline for Debt Ceiling -- WSJ

9 mei 2025, 21:10 UTC

Top Nieuws

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

9 mei 2025, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

9 mei 2025, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

9 mei 2025, 20:42 UTC

Top Nieuws

Stocks Get a Break From Trade Chaos -- WSJ

Peer Vergelijking

Prijswijziging

Quanterix Corp Prognose

Koersdoel

By TipRanks

129.73% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 12.13 USD  129.73%

Hoogste 18 USD

Laagste 7.5 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Quanterix Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

4 ratings

2

Buy

2

Hold

0

Sell

Technische score

By Trading Central

5.34 / 6.015Steun & Weerstand

Korte Termijn

Neutral Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

No Evidence

Sentiment

By Acuity

299 / 382 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.